Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation. Glenmark Life Sciences Ltd - 543322 - Appointment Of Chief Financial Officer
On the recommendations of Nomination and Remuneration Committee and approval of the Audit Committee, Board approved the appointment of Mr. Tushar P. Mistry as the Chief Financial Officer (designated as Key Managerial Personnel) of the Company with effect from June 1, 2022. Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Mr. Bhavesh Pujara has resigned as the Chief Financial Officer of the Company with effect from the close of business hours on April 22, 2022. Consequently, he also ceases to be the Key Managerial Personnel of the Company. Glenmark Life Sciences Ltd - 543322 - Outcome Of The Board Meeting - April 20, 2022
The Board of Glenmark Life Sciences Limited at its meeting held on April 20, 2022, has, inter alia, considered and approved: 1. The Audited Financial Results for the Year ended March 31, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the said results together with Management Discussion & Analysis, Press Release, Auditors Report and Declaration of unmodified opinion are enclosed herewith. These are also being made available on the website of the Company at www.glenmarklifesciences.com. 2. Recommended final Dividend of Rs. 10.50 per share (face value of Rs. 2/- each) on the Equity Share Capital of the Company for the financial year 2021 - 22 subject to the approval of the Shareholders at the ensuing Annual General Meeting. Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Enclosed please find herewith the details of Earnings Call slated for Thursday, April 21, 2022 at 8:30 a.m. - 9:30 a.m. (1ST), for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call. Glenmark Life Sciences Ltd - 543322 - Certificate From Practicing Company Secretary Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015 For The Financial Year Ended 31St March. 2022
Certificate from Practicing Company Secretary under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 for the Financial year ended 31st March. 2022 Glenmark Life Sciences Ltd - 543322 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 112130 Name of the Signatory :- Rudalf CorrieaDesignation :- Company Secretary and Compliance Officer Glenmark Life Sciences Ltd - 543322 - Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2022 And To Consider And Recommend Final Dividend, If Any, On Equity Shares For The Year Ended March 31, 2022.
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2022 ,inter alia, to consider and approve Audited Financial Results of the Company for the quarter and year ended March 31, 2022 and to consider and recommend final dividend, if any, on Equity Shares for the year ended March 31, 2022. Glenmark Life Sciences Ltd - 543322 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2022
This is to certify that all activities in relation to both physical and electronic share transfer facilities are maintained by Registrar to an issue and Share Transfer Agent 'M/s. KFin Technologies Limited' registered with Securities Exchange Board of India under Registration Number INR000000221.